Get 20% lifetime commission for referring investors to digrin.com
here.
Avidity Biosciences Inc (RNAM) Financials
Stock symbol RNAM is outdated, potentially delisted? Maybe it is available on other exchange?
RNAM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 2.0 billion | 269.5 million |
| Sept. 30, 2025 | 2.1 billion | 247.9 million |
| June 30, 2025 | 1.4 billion | 176.3 million |
| March 31, 2025 | 1.5 billion | 130.4 million |
RNAM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -175.3 million | 43.4 million |
| Sept. 30, 2025 | -156.9 million | 19.0 million |
| June 30, 2025 | -203.0 million | 17.7 million |
| March 31, 2025 | -128.6 million | 17.7 million |
RNAM Net Income
No data available :(
RNAM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 1.7 billion | 90.6 million | 45.3 million |
| Sept. 30, 2025 | 1.9 billion | 92.0 million | 46.0 million |
| June 30, 2025 | 1.2 billion | 2.4 million | 1.2 million |
| March 31, 2025 | 1.4 billion | 4.2 million | 2.1 million |
RNAM Shares Outstanding
RNAM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 5.5 million | 166.6 million | 87.2 million | - |
| Sept. 30, 2025 | 712000 | 154.9 million | 45.3 million | - |
| June 30, 2025 | 3.3 million | 138.1 million | 36.1 million | - |
| March 31, 2025 | 3.8 million | 99.5 million | 32.8 million | - |
RNAM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 860000 | 1.5 million |
| Sept. 30, 2025 | 12.5 million | 1.1 million |
| June 30, 2025 | 3.8 million | 814000 |
| March 31, 2025 | 1.6 million | 785000 |
RNAM
Price: $72.82
52 week price:
Earnings Per Share: -4.19 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 11.2 billion